Event Type
Disclosure
Mandatory
Variant
8-K
and this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of
Regulation FD Disclosure. On March 25, 2025, the Company made available the corporate presentation attached hereto as Exhibit 99.1 (the “Corporate Presentation”
Other Events. Phase 1b/2 Clinical Trial Data Release On March 25, 2025, the Company and Newsoara BioPharma Co., Ltd., a pre-commercial-stage biopharmaceutical c
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Corporate Presentation, dated March 25, 2025 104 Cover Page Interactive Data File